Market Place
Sourcing Support
Survey: 90% of animal owners trust vets but underestimate demands
24 Apr 2025 //
GLOBENEWSWIRE
Boehringer slots synthetic lethal program into oncology pipeline
23 Apr 2025 //
FIERCE BIOTECH
Boehringer Ingelheim announces succession in Chairmen and Board
17 Apr 2025 //
GLOBENEWSWIRE
Boehringer, Cue Bio partner for autoimmune & inflammatory diseases
14 Apr 2025 //
GLOBENEWSWIRE
Boehringer boosts ADC portfolio with NBE Therapeutics R&D center
03 Apr 2025 //
GLOBENEWSWIRE
Amid US uncertainty, Boehringer projects `slight` sales increase
02 Apr 2025 //
FIERCE PHARMA
Boehringer Ingelheim reaches more Patients in 2024, plans launches
02 Apr 2025 //
GLOBENEWSWIRE
Salipro Biotech, Boehringer Ingelheim Partner to Accelerate Pipeline
13 Mar 2025 //
GLOBENEWSWIRE
Cognizant and Boehringer Ingelheim Launch One Medicine Platform
11 Mar 2025 //
CONTRACTPHARMA
Spevigo Data In GPP Patient Outcomes Presented At AAD 2025
07 Mar 2025 //
PR NEWSWIRE
Boehringer wins jury verdict in Zantac retrial in Illinois
26 Feb 2025 //
ENDPTS
CDR-Life Hits Fifth Milestone With Boehringer In Geographic Atrophy
25 Feb 2025 //
BUSINESSWIRE
Boehringer Ingelheim launches new trivalent poultry vaccine
24 Feb 2025 //
GLOBENEWSWIRE
Boehringer, Partner Begin Clinical Trial For Inhaled CF Gene Therapy
20 Feb 2025 //
GLOBENEWSWIRE
OXB’s Lentiviral Tech Supports Boehringer’s Ph 1/2 CF Gene Therapy Trial
20 Feb 2025 //
GLOBENEWSWIRE
Boehringer Ingelheim Welcomes Brian As US Pharma President
20 Feb 2025 //
PR NEWSWIRE
Boehringer’s Zongertinib Gets FDA Priority Review For HER2 NSCLC
19 Feb 2025 //
GLOBENEWSWIRE
FDA Grants Review To Boehringer’s Zongertinib For HER2-Mutant NSCLC
19 Feb 2025 //
PR NEWSWIRE
Boehringer widens fibrosis drug`s potential after 2nd ph. 3 win
11 Feb 2025 //
PRESS RELEASE
Boehringer merges cancer vaccine and oncolytic virus team
25 Jan 2025 //
ENDPTS
Boehringer Updates Ph 3 Program For Iclepertin In Schizophrenia
16 Jan 2025 //
GLOBENEWSWIRE
Lonza`s Synaffix adds Boehringer to partners it with $1.3B ADC pact
10 Jan 2025 //
FIERCE BIOTECH
Boehringer Ingelheim Acquires Fourth Cancer Antibody License
09 Jan 2025 //
GLOBENEWSWIRE
Sutro, Boehringer Ingelheim Establish Commercial Cell-Free Tech
07 Jan 2025 //
GLOBENEWSWIRE
Malaysia Approves Spesolimab for Generalised Pustular Psoriasis
13 Dec 2024 //
BIOSPECTRUM
Boehringer, Lilly bring kidney disease test push to Rose Parade
11 Dec 2024 //
FIERCE PHARMA
CORE Kidney, Boehringer, Lilly Focus on Kidney Health at Parade
09 Dec 2024 //
PR NEWSWIRE
Torrent inks agreement with Boehringer to acquire 3 anti-diabetes
05 Dec 2024 //
INDPHARMAPOST
Boehringer Introduces Eurican L4 Vaccine For Leptospirosis
30 Nov 2024 //
PHARMABIZ
Latest Zantac Trial Against Boehringer Ingelheim Ends With Hung Jury
21 Nov 2024 //
REUTERS
Boehringer`s Focus On Health Equity Access To Medicine Upgrade
19 Nov 2024 //
GLOBENEWSWIRE
Boehringer Ingelheim & MTM Vision Partner on Diabetes Vision Loss
13 Nov 2024 //
PHARMABIZ
Boehringer & MTM Initiative to Combat Diabetes-related Vision Loss
12 Nov 2024 //
GLOBENEWSWIRE
Boehringer tops reputation rankings among CV patient groups
31 Oct 2024 //
FIERCE PHARMA
FDA Issues Form 483 to Boehringer Ingelheim Biopharmaceuticals
30 Oct 2024 //
FDA
Boehringer drops obesity drug from Gubra partnership
30 Oct 2024 //
FIERCE BIOTECH
Boehringer Ingelheim And WHO Foundation Promote Equitable Healthcare
15 Oct 2024 //
GLOBENEWSWIRE
Boehringer And Circle Pharma Collaborate On Novel Cancer Treatment
10 Oct 2024 //
BUSINESSWIRE
Boehringer And Circle Pharma Announce Cancer Research
09 Oct 2024 //
BUSINESSWIRE
Zealand And Boehringer Win FDA Breakthrough For Fatty Liver
07 Oct 2024 //
REUTERS
Boehringer Ingelheim Partners With NCD Alliance For Communities
27 Sep 2024 //
GLOBENEWSWIRE
Boehringer Ingelheim expands cancer research at its Vienna site
27 Sep 2024 //
PHARMABIZ
Surrozen Earns $10M Milestone in Retinal Diseases Collaboration
24 Sep 2024 //
GLOBENEWSWIRE
Boehringer`s Pulmonary Fibrosis Drug Succeeds In Phase 3, FDA Filing Planned
18 Sep 2024 //
BIOSPACE
Boehringer`s Lung Fibrosis Trial Meets Primary Endpoint
17 Sep 2024 //
FIERCE BIOTECH
Weight-loss market to see 16 new drugs by 2029, report estimates
11 Sep 2024 //
EXPRESSPHARMA
Boehringer`s Zongertinib Shows Promise In HER2 Mutated Lung Cancer
10 Sep 2024 //
PR NEWSWIRE
Boehringer`s Zongertinib Shows Encouraging Profile
09 Sep 2024 //
GLOBENEWSWIRE
Boehringer Ingelheim Plans New Geographic Atrophy Treatment
05 Sep 2024 //
GLOBENEWSWIRE
Boehringer Ingelheim Acquires Saiba Animal Health for Pet Therapeutics R&D
03 Sep 2024 //
GLOBENEWSWIRE
Boehringer Ingelheim To Present Oncology Research At WCLC
27 Aug 2024 //
GLOBENEWSWIRE
Boehringer Buys Nerio Therapeutics for $1.3B to Boost Immuno-Oncology Pipeline
30 Jul 2024 //
BIOSPACE
CHMP Recommends New Indications For SPEVIGO®
29 Jul 2024 //
GLOBENEWSWIRE
Brainomix and Boehringer Launch Strategic Partnership in Fibrosing Lung Disease
20 Jul 2024 //
PR NEWSWIRE
Boehringer Teams With GoodRx To Offer Discounted Humira Biosimilar
19 Jul 2024 //
FIERCE PHARMA
Boehringer cuts price of Humira biosimilar in bid to build use
19 Jul 2024 //
REUTERS
Boehringer Ingelheim Reports Pipeline Progress In First Half 2024
18 Jul 2024 //
GLOBENEWSWIRE
Boehringer Ingelheim India Grants Funds For Dementia Care Innovation
16 Jul 2024 //
CONTRACT PHARMA
Boehringer Ingelheim produces its own green energy
08 Jul 2024 //
GLOBENEWSWIRE
Boehringer and OSE to advance cancer immunotherapy to clinics
04 Jul 2024 //
PHARMACEUTICAL TECHNOLOGY
